#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Li-Fraumeni syndrome Pseudomyxoma peritonei Acute hepatic failure Brain stem glioma B-cell lymphoma recurrent Hyperchylomicronaemia Osteosarcoma recurrent Human papilloma virus immunisation Primary mediastinal large B-cell lymphoma Interstitial lung disease Blood iron increased Hereditary motor and sensory neuropathy Precursor T-lymphoblastic lymphoma/leukaemia recurrent Liposarcoma recurrent Langerhans' cell histiocytosis More trials…

    Learn about Rare Diseases

    Medulloblastoma – Diagnostics Skin angiosarcoma – Trials in Disease Mastocytosis Pemphigus – Life with Disease Crigler-Najjar syndrome Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Nephrotic syndrome – Basic Information Marginal zone lymphoma refractory – Basic Information Osteosarcoma Fabry’s disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Itolizumab Azelastine Omo-103 Solrikitug Abbv-668 Indocyanine Green Cytisine CAMOSTAT MESILATE ISPAGHULA HUSK SILYMARIN Betibeglogene Autotemcel Amikacin Azd8205 Abacavir Vancomycin Hydrochloride AUR200 Magrolimab Baricitinib VG801-1 Afimetoran Besilate Dihydrate More therapies…

    Learn about Your Condition

    Idiopathic pulmonary fibrosis Takayasu's arteritis Post-acute COVID-19 syndrome Cardiac arrest Benign prostatic hyperplasia Bipolar I disorder Thrombectomy Normal pressure hydrocephalus Neuromyopathy Bronchiectasis Frostbite Incisional hernia Left ventricular failure Leiomyosarcoma recurrent Fatty acid oxidation disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Female Urogenital Diseases and Pregnancy Complications

  • Study on Overactive Bladder Treatment for Women Using Clostridium Botulinum Neurotoxin Type A and Vibe System

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypertonic bladder
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Portugal

  • Study on the Effectiveness and Safety of OG-6219 and Naproxen Sodium for Women Aged 18-49 with Moderate to Severe Endometriosis Pain

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • For-6219
    • Naproxen Sodium
    Belgium Bulgaria Czechia France Germany Hungary +4

  • Study on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Denmark Iceland Sweden

  • Study on Clindamycin Use for Infection Prevention in Pregnant Women Undergoing Maternal or Fetal Surgery

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Clindamycin Phosphate
    Belgium

  • Study on the Effectiveness of Oral Sodium Bicarbonate and Intravenous Hyoscine Butylbromide for Facilitating Natural Childbirth in Pregnant Women Induced for Labor

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Labour induction
    Investigated Drugs:
    • Hyoscine Butylbromide
    • Sodium Hydrogen Carbonate
    • Sodium Chloride
    Norway

  • Study on the Effectiveness of Ipilimumab and Nivolumab for Patients with Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    The Netherlands
Previous Page
1 … 29 30 31 32
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!